Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs. Methadone for Opioid Dependence in Pregnancy
NCT03098407Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2017
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of buprenorphine in opioid use disorder (OUD) (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Number of participants who are recruited, enrolled, retained, and who complete the study at 12 months. Started Apr 2017; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03098407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098407.